Different effects of rosiglitazone and metformin on adipose tissue glucose uptake in type 2 diabetes

被引：0
|
作者：
Yuan, MS
Melendez, PA
Iwamoto, M
Lee, JS
Shoelson, SE
机构：
来源：
DIABETES | 2002年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
585
引用
收藏
页码：A145 / A145
页数：1
相关论文
共 50 条
  • [1] Different effects of rosiglitazone and metformin on adipose tissue glucose uptake in Type 2 diabetes
    Virtanen, KA
    Hällsten, K
    Parkkola, R
    Lönnqvist, F
    Lönnroth, P
    Rönnemaa, T
    Knuuti, J
    Huupponen, R
    Nuutila, P
    DIABETOLOGIA, 2002, 45 : A251 - A251
  • [2] Effects of rosiglitazone and metformin on femoral subcutaneous adipose tissue blood flow and glucose uptake in patients with type 2 diabetes
    Viljanen, APM
    Virtanen, KA
    Järvisalo, MJ
    Hällsten, K
    Rönnemaa, T
    Iozzo, P
    Ferrannini, E
    Nuutila, P
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 : S286 - S287
  • [3] Effects of rosiglitazone and metformin on femoral subcutaneous adipose tissue blood flow and glucose uptake in patients with type 2 diabetes
    Viljanen, APM
    Virtanen, KA
    Jarvisalo, MJ
    Hällsten, K
    Rönnemaa, T
    Iozzo, P
    Ferrannini, E
    Nuutila, P
    DIABETES, 2004, 53 : A318 - A318
  • [4] Differential effects of rosiglitazone and metformin on adipose tissue distribution and glucose uptake in type 2 diabetic subjects
    Virtanen, KA
    Hällsten, K
    Parkkola, R
    Janatuinen, T
    Lönnqvist, F
    Viljanen, T
    Rönnemaa, T
    Knuuti, J
    Huupponen, R
    Lönnroth, P
    Nuutila, P
    DIABETES, 2003, 52 (02) : 283 - 290
  • [5] Rosiglitazone treatment increases subcutaneous adipose tissue glucose uptake in parallel with perfusion in patients with type 2 diabetes:: A double-blind, randomized study with metformin
    Viljanen, APM
    Virtanen, KA
    Järvisalo, MJ
    Hällsten, K
    Parkkola, R
    Rönnemaa, T
    Lönnqvist, F
    Iozzo, P
    Ferrannini, E
    Nuutila, P
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (12): : 6523 - 6528
  • [6] Rosiglitazone but not metformin enhances insulin stimulated myocardial glucose uptake in patients with type 2 diabetes
    Nuutila, P
    Hällsten, K
    Virtanen, KA
    Lönnqvist, F
    Viikari, J
    Rönnemaa, T
    Knuuti, J
    DIABETES, 2002, 51 : A142 - A142
  • [7] Effects of metformin and rosiglitazone monotherapy on insulin mediated hepatic glucose uptake, and their relation to visceral fat in type 2 diabetes
    Iozzo, P
    Hallsten, K
    Oikonen, V
    Virtanen, K
    Parkkola, R
    Kemppainen, J
    Solin, O
    Lonnqvist, F
    Ferrannini, E
    Knuuti, J
    Nuutila, P
    DIABETES, 2003, 52 : A76 - A76
  • [8] Effects of metformin and rosiglitazone monotherapy on insulin-mediated hepatic glucose uptake and their relation to visceral fat in type 2 diabetes
    Iozzo, P
    Hallsten, K
    Oikonen, V
    Virtanen, KA
    Parkkola, R
    Kemppainen, J
    Solin, O
    Lonnqvist, F
    Ferrannini, E
    Knuuti, J
    Nuutila, P
    DIABETES CARE, 2003, 26 (07) : 2069 - 2074
  • [9] Effects of metformin and rosiglitazone monotherapy on insulin-mediated hepatic glucose uptake and their relation to visceral fat in Type 2 diabetes.
    Lautamäki, RM
    Iozzo, P
    Hällsten, K
    Virtanen, KA
    Kemppainen, J
    Lönnqvist, F
    Ferrannini, E
    Knuuti, J
    Nuutila, P
    DIABETOLOGIA, 2003, 46 : A62 - A62
  • [10] Effects of metformin and rosiglitazone treatment on insulin signaling and glucose uptake in patients with newly diagnosed type 2 diabetes -: A randomized controlled study
    Karlsson, HKR
    Hällsten, K
    Björnholm, M
    Tsuchida, H
    Chibalin, AV
    Virtanen, KA
    Heinonen, OJ
    Lönnqvist, F
    Nuutila, P
    Zierath, JR
    DIABETES, 2005, 54 (05) : 1459 - 1467
12345